-
1
-
2by Sophie Vimont, Anders Boyd, Alexandre Bleibtreu, Marcelle Bens, Jean-Michel Goujon, Louis Garry, Olivier Clermont, Erick Denamur, Guillaume Arlet, Alain VandewalleGet full text
Published 2012-01-01
Article -
3by Nathan Peiffer-Smadja, François-Daniel Ardellier, Pauline Thill, Anne-Lise Beaumont, Gaud Catho, Lindsay Osei, Vincent Dubée, Alexandre Bleibtreu, Adrien Lemaignen, Michaël ThyGet full text
Published 2020-10-01
Article -
4by Yaniss Belaroussi, Paul Roblot, Nathan Peiffer-Smadja, Thomas Delaye, Simone Mathoulin-Pelissier, Joffrey Lemeux, Gwenaël Le Moal, Eric Caumes, France Roblot, Alexandre BleibtreuGet full text
Published 2020-11-01
Article -
5Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Studyby Alexandre Bleibtreu, Laurent Dortet, Remy A. Bonnin, Benjamin Wyplosz, Sophie-Caroline Sacleux, Liliana Mihaila, Hervé Dupont, Helga Junot, Vincent Bunel, Nathalie Grall, Keyvan Razazi, Clara Duran, Pierre Tattevin, Aurélien Dinh, on behalf of the Cefiderocol French Study GroupGet full text
Published 2021-01-01
Article -
6
-
7by Arsene Mekinian, David Saadoun, Eric Vicaut, Sara Thietart, Bertrand Lioger, Patrick Jego, Alexandre Bleibtreu, Nicolas Limal, Jerome Connault, Jacques-Eric Gottenberg, Pauline Lhorte, Jean Pierre Bertola, Juliette Delforge, Nicole Ferreira-Maldent, Antoinette Perlat, Zohra Talib, Matthieu Vautier, Léa Savey, Isabelle Quiere, Patrice Cacoub, Olivier Fain, for the French Takayasu networkGet full text
Published 2020-09-01
Article